Breast Cancer Clinical Trials in Boston

Showing 141-160 of 598 trials

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

NCT02653755

This research study is a way of gaining new knowledge about whether patients can omit radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify which patients may not need radiation.

Breast Cancer Radiation

Dana-Farber Cancer Institute671 participantsStarted May 2016

Baltimore, Maryland, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +3 more locations

Active Not Recruiting< 1 mile

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

NCT06234488

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

Breast CancerBreast NeoplasmsBreast Adenocarcinoma+4 more

Medical College of Wisconsin125 participantsStarted Dec 2023

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +19 more locations

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Breast Cancer Trials in Other Cities

Olaparib In Metastatic Breast Cancer

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease

Elevate! : An Elderly Breast Cancer Cohort Study

Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Study of AVZO-021 in Patients With Advanced Solid Tumors

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Other Conditions in Boston